Menu

Legislative

Leading 340B Critic Carter Faces Tough Race in Georgia’s GOP U.S. Senate Primary Today

Shannon Young, Associate Editor/Senior Writer 340B Report Views
Buddy Carter official portrait
U.S. Rep. Earl “Buddy” Carter will go up against U.S. Rep. Mike Collins, Derek Dooley, John Coyne III and Jonathan McColumn in Georgia’s May 19 GOP U.S. Senate primary.
A Georgia congressman, who has been a longtime 340B program critic, will face off today against four other GOP contenders [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Key 340B Critic Loses Reelection Bid in Louisiana GOP U.S. Senate Primary

Shannon Young, Associate Editor/Senior Writer 340B Report Views
U.S. Sen. BIll Cassidy (center), one of the 340B program’s biggest critics, will not return to Congress in 2027 after placing third in Saturday’s Louisiana GOP Senate primary behind U.S. Rep. Julia Letlow (left) and Louisiana State Treasurer John Fleming (right).
One of the 340B program’s biggest critics and advocates for change will not return to Congress in 2027 after placing [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

340B Stakeholders Cheer the Addition of Sen. Boozman to 340B Working Group

Luke Zarzecki, National Correspondent 340B Report Views
340B drug pricing program stakeholders cheered on U.S. Sen. John Boozman's (R-Ark.) addition to the bipartisan Senate working group that’s drafting long-awaited 340B reform legislation.
340B drug pricing program stakeholders—from both sides of the debate over its future—cheered on the May 14 addition of an [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Novo Nordisk Exempts 10 States from In-House Claims Data Reqs, Merck Exempts Washington from CP Restrictions, Reimplements Them in Three States 

Luke Zarzecki, National Correspondent 340B Report Views
Novo Nordisk and Merck exempted certain states and reversed exemptions in others, following court rulings, threats of enforcement actions and a new state law.
Two major pharmaceutical companies exempted certain states and reversed exemptions in others, following court rulings, threats of enforcement actions and [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Minnesota Lawmakers Fail to Advance Bill Strengthening 340B Contract Pharmacy Access Law

William Newton, Associate Editor/Senior Writer 340B Report Views
Minnesota state house
Minnesota state lawmakers failed to pass a bill to strengthen the state's 340B contract pharmacy access bill before the legislative session recently ended.
Minnesota state lawmakers failed to pass a bill that would have strengthened the state’s existing 340B contract pharmacy access law [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Breaking News

U.S. Senate Bipartisan 340B Working Group Adds New Republican Member

Luke Zarzecki, National Correspondent 340B Report Views
Sen. John Boozman headshot
U.S. Sen. John Boozman (R-Ark.) officially joined the “group of six” (G6) senators behind high-profile 340B program legislation on May 14.
An Arkansas Republican, who has historically supported 340B providers, announced Friday that he has joined the bipartisan U.S. Senate working [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Key U.S. Senate 340B Critic Faces Tough Reelection Bid in Louisiana’s Saturday GOP Primary

Shannon Young, Associate Editor/Senior Writer 340B Report Views
Letlow, Cassidy and Fleming headshots
U.S. Sen. Bill Cassidy (center) will face U.S. Rep. Julia Letlow (left) and Louisiana State Treasurer John Fleming (right) in Louisiana’s May 16 GOP U.S. Senate primary election. (Photos courtesy: Congressional websites, Louisiana State Treasurer's website)
A high-ranking U.S. senator, who’s been a chief critic of the 340B program, will square off Saturday against two GOP [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Exclusive

Novo Nordisk Says it Won’t Require Tennessee Providers to Report Claims Data Following AG Warning 

Luke Zarzecki, National Correspondent 340B Report Views
Novo Nordisk recently told a Tennessee official that it will not require state providers to submit 340B claims data after the state Attorney General's Office warned that the drugmaker’s new reporting requirements violated Tennessee law.
A major drugmaker recently told a Tennessee official that it will not require state providers to submit 340B claims data [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Federal Appeals Court Denies Novartis’ Rehearing Request on Mississippi’s 340B Contract Pharmacy Access Law

William Newton, Associate Editor/Senior Writer 340B Report Views
The U.S. 5th Circuit Court of Appeals
The U.S. 5th Circuit Court of Appeals declined to reconsider its ruling in favor of Mississippi's 340B contract pharmacy access law.
A New Orleans federal appeals court recently denied a major pharmaceutical manufacturer’s request to reconsider a ruling in favor of [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

WSJ Editorial Board Op-Ed Points to North Dakota Judge’s Contract Pharmacy Ruling, Calls 340B ‘Scam’ 

Luke Zarzecki, National Correspondent 340B Report Views
The Wall Street Journal's editorial board recently highlighted a federal judge’s ruling against North Dakota’s contract pharmacy access law to denounce the 340B program as “healthcare grift” in need of federal reform.
A major newspaper’s editorial board recently highlighted a federal judge’s ruling against North Dakota’s contract pharmacy access law to denounce [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live